Skip to content

Effect of probiotic in premenstrual syndrome

Effect of synbiotic supplementation on reduction of severity of anxiety and depression in women with premenstrual syndrome

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20180425039412N1
Enrollment
160
Registered
2019-03-10
Start date
2018-09-23
Completion date
Unknown
Last updated
2019-03-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

premenstrual syndrome.

Interventions

Intervention 1: 80 students and medical staff of Iran University of Medical Sciences receive synbiotic supplement with 10 microbial population to 9 colonies per gram, containing (Lactobacillus gasser

Sponsors

Iran University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 40 Years

Inclusion criteria

Inclusion criteria: Age range 18-40 years BMI Between 35 and 25 Affection of premenstrual syndrome based on PSST questionnaire The normal duration of bleeding (3-7 days in the 3 months before entering the study) and the regular monthly cycle Lack of chronic systemic diseases and diseases related to the ovary Lack of liver disease, bile duct disease, gastrointestinal and intestinal diseases, kidney disease, parathyroid thyroid and non-hyperphosphatemia Non-use of probiotic and probiotic-based supplements over the past 6 months Not using supplements containing vitamins and minerals supplement W3 or fish oil Non-development of neurological diseases and no use of psychosomatic drugs Non-use of hormonal drugs The desire to participate in the study and written consent written consent Absence of iron deficiency anemia Non-use of steroidal and non-steroidal anti-inflammatory drugs, Anti epileptic drugs, anti cholesterolemic drugs, anti-acid drugs, diuretics and laxatives Not using any medication or dietary supplement that affects weight

Exclusion criteria

Exclusion criteria: Consumption of probiotic supplementation from 3 months before study Affection of acute and chronic diseases of depression Iron deficiency anemia

Design outcomes

Primary

MeasureTime frame
Depression. Timepoint: Before the intervention, 1.2 and 3 months after the intervention. Method of measurement: questionnaire.

Secondary

MeasureTime frame
Anxiety. Timepoint: Before the intervention, 1.2 and 3 months after the intervention. Method of measurement: questionnaire Before intervention and 1.2 and 3 months after the intervention.;BMI. Timepoint: Before the intervention, 1.2 and 3 months after the intervention. Method of measurement: Weight ratio (kg) to squared height (m).;Waist circumference. Timepoint: Before the intervention, 1.2 and 3 months after the intervention. Method of measurement: meter.;Nutritional status. Timepoint: Before the intervention, 1.2 and 3 months after the intervention. Method of measurement: Measurement of energy and nutrients intake using 24-hour dietary recall method and anthropometric measurement using scale and stadiometer.;Physical Activity. Timepoint: Before the intervention, 1.2 and 3 months after the intervention. Method of measurement: IPAQ questionnaire.;Quality of life. Timepoint: Before the intervention, 1.2 and 3 months after the intervention. Method of measurement: ququestionnaire.;Fat percent. Timepoint: Before the intervention, 1.2 and 3 months after the intervention. Method of measurement: enbody.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr Mitra Zarrati

Iran University of Medical Sciences

zarrati.m@iums.ac.ir+98 21 8670 4814

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026